Medical Professionals Online

Importance Of Penile Prostheses In The Treatment Of ED

May 08, 2017

BERLIN, GERMANY (UroToday) - Harris M. Nagler, MD, Chair Sol and Margaret Berger Department of Urology, Chief of GME/Academic Affairs, Beth Israel Medical Center and Professor of Urology, Albert Einstein College of Medicine presented a discussion emphasizing the importance of penile prostheses in the treatment of ED, "Penile Prosthesis-petering out or standing strong."

In this discussion, Dr. Nagler pointed out that the predominant risk factors for ED, including diabetes and cardiovascular disease, are continuing to increase. The worldwide incidence of ED has been estimated to be 322 million men by 2025. It is estimated that there will be 23 million diabetic men in the US alone by 2030.

Dr. Nagler emphasized that the diagnosis and treatment of prostate cancer will further the need for effective ED treatmentsince, despite advancements, each of the commonly employed modalities frequently result in ED.

The drop-out rates for each of these therapies was reviewed. Even the oral medications have a significant drop-out rate as reported by Sato in the International Journal of Urology (2007).

The high satisfaction rate from prosthetic surgery was discussed. World wide the number of prostheses implanted annually has increased from around 12,000 in 1998 to nearly 25,000 in 2006.

Prosthesis surgery is here to stay.

Presented by Harris M. Nagler, MD, at the Annual Meeting of the American Urological Association - New York Section - September 6 - 13, 2008 - Berlin, Germany

Reported by UroToday Contributing Editor Harris M. Nagler, MD

UroToday - the only urology website with original content global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday

Copyright © 2008 - UroToday